Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.
Article Details
- CitationCopy to clipboard
Lee LY, Hernandez D, Rajkhowa T, Smith SC, Raman JR, Nguyen B, Small D, Levis M
Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.
Blood. 2017 Jan 12;129(2):257-260. doi: 10.1182/blood-2016-10-745133. Epub 2016 Dec 1.
- PubMed ID
- 27908881 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs